Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for SARTORIUS (SARTF : OTC)

• Company Description    Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. Number of Employees: 13,528

• Price / Volume Information    Yesterday's Closing Price: $208.82 Daily Weekly Monthly 20 Day Moving Average: 4 shares Shares Outstanding: (millions) Market Capitalization: $ (millions) Beta: 1.07 52 Week High: $243.35 52 Week Low: $165.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 5.04% 0.29% 12 Week 26.18% 6.49% Year To Date 13.49% 6.63%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL OTTO-BRENNER-STRASSE 20 - GOETTINGEN,2M 37079 DEU ph: 49-55-130-80 fax: 49-55-1308-3289 ben.orzelek@sartorius.com http://www.sartorius.com

• General Corporate Information    Officers Joachim Kreuzburg - Chief Executive Officer and Chairman Florian Funck - Chief Financial Officer Rene Faber - Member of the Executive Board Alexandra Gatzemeyer - Member of the Executive Board Rainer Lehmann - Member of the Executive Board Peer Information SARTORIUS (ABMD) SARTORIUS (DMDS) SARTORIUS (CPWY.) SARTORIUS (EQUR) SARTORIUS (ECIA) SARTORIUS (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: D6705R101 SIC: 3843 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 07/17/25 Share - Related Items Shares Outstanding: Most Recent Split Date: (:1) Beta: 1.07 Market Capitalization: $ (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/17/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 45.59 PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 16.36% vs. Previous Quarter: 15.32% Sales Growth vs. Year Ago Period: 4.38% vs. Previous Quarter: -3.98% ROE 06/30/25 - - 03/31/25 - 7.62 12/31/24 - 7.29 ROA 06/30/25 - - 03/31/25 - 2.92 12/31/24 - 2.74 Current Ratio 06/30/25 - - 03/31/25 - 1.46 12/31/24 - 1.46 Quick Ratio 06/30/25 - - 03/31/25 - 0.93 12/31/24 - 0.92 Operating Margin 06/30/25 - - 03/31/25 - 8.52 12/31/24 - 8.25 Net Margin 06/30/25 - - 03/31/25 - 2.76 12/31/24 - 2.48 Pre-Tax Margin 06/30/25 - - 03/31/25 - 6.16 12/31/24 - 5.53 Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - - Inventory Turnover 06/30/25 - - 03/31/25 - 2.22 12/31/24 - 2.04 Debt-to-Equity 06/30/25 - - 03/31/25 - 1.09 12/31/24 - 1.07 Debt-to-Capital 06/30/25 - - 03/31/25 - 52.26 12/31/24 - 51.67

Powered by Zacks Investment Research ©